It is important to note that PD-L1 in tumor cells has functions other than as an immune checkpoint ligand, including stimulation of cancer progression, promotion of EMT, acquisition of tumor-initiating potential, and resistance to apoptosis [15]. This evidence concerns the gene CD274 and neoplasm.